3 búsqueda de la palabra clave 'stomach'

Laparoscopic management of gastric gastrointestinal stromal tumors / Álvaro Enrique Sanabria Quiroga ; Juan Camilo Correa Cote    

Público ISBD Título : Laparoscopic management of gastric gastrointestinal stromal tumors Tipo de documento : documento electrónico Autores : Álvaro Enrique Sanabria Quiroga, ; Juan Camilo Correa Cote, Fecha de publicación : 2014 Títulos uniformes : World Journal of Gastrointestinal Endoscopy Idioma : Inglés (eng) Palabras clave : Gastrointestinal stromal tumors  Laparoscopy  Surgery  Stomach  Gastrectomy Resumen : Gastrointestinal stromal tumors (GISTs) are the most frequent gastrointestinal tumors of mesodermal origin. Gastric GISTs represent approximately 70% of all gastrointestinal GISTs. The only curative option is surgical resection. Many surgical groups have shown good results with the laparoscopic approach. There have not been any randomized controlled trials comparing the open vs laparoscopic approach, and all recommendations have been based on observational studies. The experience obtained from gastric laparoscopic surgery during recent decades and the development of specific devices have allowed the treatment of most gastric GISTs through the laparoscopic approach. Mención de responsabilidad : Juan Correa-Cote, Carlos Morales-Uribe, Alvaro Sanabria Referencia : World J Gastrointest Endosc. Jul 2014;6(7):296-303. DOI (Digital Object Identifier) : 10.4253/wjge.v6.i7.296 Derechos de uso : CC BY-NC En línea : https://www.wjgnet.com/1948-5190/full/v6/i7/296.htm Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3820 Laparoscopic management of gastric gastrointestinal stromal tumors [documento electrónico] / Álvaro Enrique Sanabria Quiroga, ; Juan Camilo Correa Cote,  . - 2014. Obra : World Journal of Gastrointestinal Endoscopy Idioma : Inglés (eng) Palabras clave : Gastrointestinal stromal tumors  Laparoscopy  Surgery  Stomach  Gastrectomy Resumen : Gastrointestinal stromal tumors (GISTs) are the most frequent gastrointestinal tumors of mesodermal origin. Gastric GISTs represent approximately 70% of all gastrointestinal GISTs. The only curative option is surgical resection. Many surgical groups have shown good results with the laparoscopic approach. There have not been any randomized controlled trials comparing the open vs laparoscopic approach, and all recommendations have been based on observational studies. The experience obtained from gastric laparoscopic surgery during recent decades and the development of specific devices have allowed the treatment of most gastric GISTs through the laparoscopic approach. Mención de responsabilidad : Juan Correa-Cote, Carlos Morales-Uribe, Alvaro Sanabria Referencia : World J Gastrointest Endosc. Jul 2014;6(7):296-303. DOI (Digital Object Identifier) : 10.4253/wjge.v6.i7.296 Derechos de uso : CC BY-NC En línea : https://www.wjgnet.com/1948-5190/full/v6/i7/296.htm Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3820

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000395	AC-2014-061	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2014-061.pdf Adobe Acrobat PDF

Ghrelin: A GH-releasing, appetite-regulating gastric hormone / Luis Vicente Syro Moreno  

Público ISBD Título : Ghrelin: A GH-releasing, appetite-regulating gastric hormone Tipo de documento : documento electrónico Autores : Luis Vicente Syro Moreno, Fecha de publicación : 2013 Títulos uniformes : Advances in Neuroimmune Biology Idioma : Inglés (eng) Palabras clave : Growth hormone  stomach  orphan receptor Resumen : Ghrelin is a hormone that stimulates growth hormone (GH) release, and regulates appetite and feeding habits. It is synthesized and expressed to varying degrees in several organs and neoplasms. Its presence has been reported in the gastrointestinal and respiratory tracts, endocrine organs, cardiovascular system, kidney and central nervous system. Ghrelin producing cells can be demonstrated in the stomach, intestines, pancreas, kidneys, brain, and pituitary. The present review summarizes findings regarding the function and regulation of ghrelin in different organs and in various diseases. Mención de responsabilidad : Di Michele, Joseph; Rotondo, Fabio; Kovacs, Kalman; Di Ieva, Antonio; Syro, Luis V.; Latta, Eleanor; Cusimano, Michael D. DOI (Digital Object Identifier) : 10.3233/NIB-130051 En línea : https://content.iospress.com/articles/advances-in-neuroimmune-biology/nib130051 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4524 Ghrelin: A GH-releasing, appetite-regulating gastric hormone [documento electrónico] / Luis Vicente Syro Moreno,  . - 2013. Obra : Advances in Neuroimmune Biology Idioma : Inglés (eng) Palabras clave : Growth hormone  stomach  orphan receptor Resumen : Ghrelin is a hormone that stimulates growth hormone (GH) release, and regulates appetite and feeding habits. It is synthesized and expressed to varying degrees in several organs and neoplasms. Its presence has been reported in the gastrointestinal and respiratory tracts, endocrine organs, cardiovascular system, kidney and central nervous system. Ghrelin producing cells can be demonstrated in the stomach, intestines, pancreas, kidneys, brain, and pituitary. The present review summarizes findings regarding the function and regulation of ghrelin in different organs and in various diseases. Mención de responsabilidad : Di Michele, Joseph; Rotondo, Fabio; Kovacs, Kalman; Di Ieva, Antonio; Syro, Luis V.; Latta, Eleanor; Cusimano, Michael D. DOI (Digital Object Identifier) : 10.3233/NIB-130051 En línea : https://content.iospress.com/articles/advances-in-neuroimmune-biology/nib130051 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4524

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001023	AC-2013-110	Archivo digital	Producción Científica	Artículos científicos	Disponible

Initial experience with Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction / Rodrigo Castaño Llano  

Público ISBD Título : Initial experience with Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction Tipo de documento : documento electrónico Autores : Rodrigo Castaño Llano, Fecha de publicación : 2001 Títulos uniformes : Journal of Vascular Interventional Radiology Idioma : Inglés (eng) Palabras clave : Duodenum  stenosis or obstruction  Gastrointestinal tract  interventional procedures  Stents and prostheses  Stomach Resumen : PURPOSE: Initial experience with use of Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction is reported. MATERIALS AND METHODS: Sixteen consecutive patients with malignant gastroduodenal obstruction were treated with peroral placement of Song's covered duodenal stent. The mean age was 58 years (range, 28–90 y). Gastroduodenal obstruction was caused by gastric (n = 8), metastatic (n = 2), gallbladder (n = 3), pancreatic (n = 2), or ampullary (n = 1) cancer. The disease was considered inoperable in all patients. With use of a flexible 20-F introducing system, seven fully covered, three uncovered, and 10 partially covered duodenal stents were placed under fluoroscopic guidance. RESULTS: The technical success rate was 94% (15 of 16) with no major complications. Symptoms of gastroduodenal obstruction improved in 14 patients. Stent migration was observed in three of seven fully covered stents. Patients with migrated stents required endoscopic stent removal and placement of uncovered duodenal stents. Tumor ingrowth was observed in two thirds of uncovered stents. In the 10 procedures with partially covered duodenal stents, no migration or tumor ingrowth was observed. All patients died 1–48 weeks (mean, 12 weeks) after stent placement. CONCLUSION: Peroral placement of Song's covered duodenal stent is a feasible and effective method of palliation in the majority of patients with malignant gastroduodenal obstruction. Migration of fully covered stents and tumor ingrowth of uncovered stents are important limitations that can be overcome with the use of a partially covered duodenal stent. Mención de responsabilidad : Jorge E. Lopera, MD Oscar Alvarez, MD Rodrigo Castaño, MD Wilfrido Castañeda-Zuñiga, MD Referencia : J Vasc Interv Radiol. 2001 Nov;12(11):1297-303. DOI (Digital Object Identifier) : 10.1016/S1051-0443(07)61555-3 PMID : 11698629 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1051044307615553 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4391 Initial experience with Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction [documento electrónico] / Rodrigo Castaño Llano,  . - 2001. Obra : Journal of Vascular Interventional Radiology Idioma : Inglés (eng) Palabras clave : Duodenum  stenosis or obstruction  Gastrointestinal tract  interventional procedures  Stents and prostheses  Stomach Resumen : PURPOSE: Initial experience with use of Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction is reported. MATERIALS AND METHODS: Sixteen consecutive patients with malignant gastroduodenal obstruction were treated with peroral placement of Song's covered duodenal stent. The mean age was 58 years (range, 28–90 y). Gastroduodenal obstruction was caused by gastric (n = 8), metastatic (n = 2), gallbladder (n = 3), pancreatic (n = 2), or ampullary (n = 1) cancer. The disease was considered inoperable in all patients. With use of a flexible 20-F introducing system, seven fully covered, three uncovered, and 10 partially covered duodenal stents were placed under fluoroscopic guidance. RESULTS: The technical success rate was 94% (15 of 16) with no major complications. Symptoms of gastroduodenal obstruction improved in 14 patients. Stent migration was observed in three of seven fully covered stents. Patients with migrated stents required endoscopic stent removal and placement of uncovered duodenal stents. Tumor ingrowth was observed in two thirds of uncovered stents. In the 10 procedures with partially covered duodenal stents, no migration or tumor ingrowth was observed. All patients died 1–48 weeks (mean, 12 weeks) after stent placement. CONCLUSION: Peroral placement of Song's covered duodenal stent is a feasible and effective method of palliation in the majority of patients with malignant gastroduodenal obstruction. Migration of fully covered stents and tumor ingrowth of uncovered stents are important limitations that can be overcome with the use of a partially covered duodenal stent. Mención de responsabilidad : Jorge E. Lopera, MD Oscar Alvarez, MD Rodrigo Castaño, MD Wilfrido Castañeda-Zuñiga, MD Referencia : J Vasc Interv Radiol. 2001 Nov;12(11):1297-303. DOI (Digital Object Identifier) : 10.1016/S1051-0443(07)61555-3 PMID : 11698629 En línea : https://linkinghub.elsevier.com/retrieve/pii/S1051044307615553 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4391

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000891	AC-2001-002	Archivo digital	Producción Científica	Artículos científicos	Disponible